Shares of Humana and other health insurers fell Thursday after the Centers for Medicare & Medicaid Services said it plans to take a more "aggressive" approach to auditing Medicare Advantage plans.

Humana maintains a healthy balance sheet, in our opinion. Most of its cash and investments ($24 billion as of mid-2024) is held at its subsidiaries, though, and the company aims to hold about $500 ...

Shares of Humana Inc. rallied 3.94% to $247.34 Monday, on what proved to be an all-around positive trading session for the ...

Shares of Humana Inc. rallied 4.61% to $237.96 Friday, on what proved to be an all-around favorable trading session for the ...

Humana has a P/E ratio of 16.4 based on its 12 month trailing earnings per share of $14.17. Considering its future earnings ...

Donald Trump on Wednesday blamed his presidential predecessor, Joe Biden, for the stock market’s weak performance, as the main U.S. indexes eked out gains despite a report showed the economy has ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue ... Analysts typically rate each stock once per quarter. Some analysts will also offer forecasts ...

Financial giants have made a conspicuous bullish move on Humana ... present market position and performance In the last month, 5 experts released ratings on this stock with an average target ...

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook. According to InvestingPro analysis, Humana currently appears ...